The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27777011 |
92 |
Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases. |
Depaul University |
| 24900651 |
50 |
Irreversible inhibitors of cysteine proteases. |
Dart Neuroscience |
| 19715320 |
87 |
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation. |
University of Florida |
| 19908842 |
84 |
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. |
National Human Genome Research Institute |
| 15686936 |
210 |
Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors. |
Merck Frosst Centre For Therapeutic Research |
| 28615111 |
24 |
Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives. |
Universit£ |
| 29648825 |
47 |
Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne. |
Nestl� |
| 18307303 |
75 |
Discovery of selective aminothiazole aurora kinase inhibitors. |
Novartis |
| 14698155 |
68 |
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. Part 4: Heterocycles at C3. |
Bristol-Myers Squibb |
Search and Browse
